BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29148140)

  • 1. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
    Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
    Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
    Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease.
    Dragu R; Hardak E; Ohanyan A; Adir Y; Aronson D
    Int J Cardiol; 2019 Sep; 290():138-143. PubMed ID: 31126737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
    Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
    Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
    Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
    Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline diastolic pressure gradient and pressure reduction in chronic heart failure patients implanted with the CardioMEMS™ HF sensor.
    Wolfson AM; Grazette L; Saxon L; Nazeer H; Shavelle DM; Jermyn R
    ESC Heart Fail; 2018 Jun; 5(3):316-321. PubMed ID: 29498245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.
    Assad TR; Hemnes AR; Larkin EK; Glazer AM; Xu M; Wells QS; Farber-Eger EH; Sheng Q; Shyr Y; Harrell FE; Newman JH; Brittain EL
    J Am Coll Cardiol; 2016 Dec; 68(23):2525-2536. PubMed ID: 27931609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.
    Tedford RJ; Beaty CA; Mathai SC; Kolb TM; Damico R; Hassoun PM; Leary PJ; Kass DA; Shah AS
    J Heart Lung Transplant; 2014 Mar; 33(3):289-97. PubMed ID: 24462554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    Ibe T; Wada H; Sakakura K; Ugata Y; Maki H; Yamamoto K; Seguchi M; Taniguchi Y; Jinnouchi H; Momomura SI; Fujita H
    PLoS One; 2021; 16(3):e0247987. PubMed ID: 33651852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
    Nagy AI; Venkateshvaran A; Merkely B; Lund LH; Manouras A
    Eur J Heart Fail; 2017 Jan; 19(1):88-97. PubMed ID: 27748008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
    Ghio S; Crimi G; Pica S; Temporelli PL; Boffini M; Rinaldi M; Raineri C; Scelsi L; Pistono M; Totaro R; Guida S; Oltrona Visconti L
    PLoS One; 2017; 12(11):e0188383. PubMed ID: 29176890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
    Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension.
    Lim HS; Howell N; Ranasinghe A
    Int J Artif Organs; 2017 Mar; 40(2):67-73. PubMed ID: 28315502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
    Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.